Relmada Therapeutics (RLMD)
(Delayed Data from NSDQ)
$3.08 USD
+0.08 (2.67%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $3.07 -0.01 (-0.32%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.83 | 0.00% |
Earnings Summary
For their last quarter, Relmada Therapeutics (RLMD) reported earnings of -$0.72 per share, beating the Zacks Consensus Estimate of $-0.90 per share. This reflects a positive earnings surprise of 20.00%. Look out for RLMD's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.83 per share, reflecting a year-over-year increase of 1.19%.
Earnings History
Price & Consensus
Zacks News for RLMD
Biotech Stock Roundup: NERV, RLMD Down on Updates, MRNA, NVAX's News & More
RLMD: What are Zacks experts saying now?
Zacks Private Portfolio Services